Scholarlink

Background <p>The Minimal Clinically Important Difference (MCID) is a crucial measure in clinical research, reflecting the smallest change in symptoms that patients perceive as beneficial. While MCID values have been established for various symptoms in Parkinson’s disease (PD), they remain underexplored in the context of depression.</p> Objective <p>This study aims to determine MCID values for three commonly used depression scales in PD: The Beck Depression Inventory (BDI-II), the Hospital Anxiety and Depression Scale – Depression subscale (HADS-D), and the 15-item Geriatric Depression Scale (GDS-15).</p> Methods <p>A total of 112 individuals with PD and depression (mean age = 70.91 ± 3.12 years) participated in a 10-week cognitive behavioral therapy program. The MCID values were estimated using both distribution-based and anchor-based methods. The Global Rating of Change (GRoC) scale was used as an anchor to assess perceived changes in depressive symptoms.</p> Results <p>MCID values were refined using the mean difference approach, resulting in the following: -5.79 points for the BDI-II, -3.52 points for the HADS-D, and − 3.05 points for the GDS-15, all with statistical significance (<i>p</i> &lt; 0.001). Using Youden’s index, the optimal MCID cut-off values were ≤ -3 points for BDI-II, ≤ -2 points for HADS-D, and ≤ -2 points for GDS-15, with high sensitivity and specificity for each. The MCID values derived from the distribution-based method for the BDI-II, HADS-D, and GDS-15 were 5.57–3.55, 1.11–3.07, and 0.96–2.66 points, respectively.</p> Conclusions <p>This study establishes MCID thresholds for commonly used depression scales in PD. These benchmarks are essential for improving clinical decision-making and evaluating the effectiveness of interventions in both clinical and research settings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Determining clinically meaningful change: minimal clinically important difference for common depression scales in older adults with parkinson’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月24日

查看全文
  • Hossein Soltaninejad,
  • Ghorban Taghizadeh,
  • Negin Eissazade,
  • Parvaneh Taghavi Azar Sharabiani,
  • Pariya Parchini,
  • Seyede Zohreh Jazaeri,
  • Maryam Mehdizadeh

摘要

Background

The Minimal Clinically Important Difference (MCID) is a crucial measure in clinical research, reflecting the smallest change in symptoms that patients perceive as beneficial. While MCID values have been established for various symptoms in Parkinson’s disease (PD), they remain underexplored in the context of depression.

Objective

This study aims to determine MCID values for three commonly used depression scales in PD: The Beck Depression Inventory (BDI-II), the Hospital Anxiety and Depression Scale – Depression subscale (HADS-D), and the 15-item Geriatric Depression Scale (GDS-15).

Methods

A total of 112 individuals with PD and depression (mean age = 70.91 ± 3.12 years) participated in a 10-week cognitive behavioral therapy program. The MCID values were estimated using both distribution-based and anchor-based methods. The Global Rating of Change (GRoC) scale was used as an anchor to assess perceived changes in depressive symptoms.

Results

MCID values were refined using the mean difference approach, resulting in the following: -5.79 points for the BDI-II, -3.52 points for the HADS-D, and − 3.05 points for the GDS-15, all with statistical significance (p < 0.001). Using Youden’s index, the optimal MCID cut-off values were ≤ -3 points for BDI-II, ≤ -2 points for HADS-D, and ≤ -2 points for GDS-15, with high sensitivity and specificity for each. The MCID values derived from the distribution-based method for the BDI-II, HADS-D, and GDS-15 were 5.57–3.55, 1.11–3.07, and 0.96–2.66 points, respectively.

Conclusions

This study establishes MCID thresholds for commonly used depression scales in PD. These benchmarks are essential for improving clinical decision-making and evaluating the effectiveness of interventions in both clinical and research settings.